A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome

N. Daver, H. Kantarjian, F. Ravandi, E. Estey, X. Wang, G. Garcia-Manero, E. Jabbour, M. Konopleva, S. O'Brien, S. Verstovsek, T. Kadia, C. Dinardo, S. Pierce, X. Huang, N. Pemmaraju, M. Diaz-Pines-Mateo, J. Cortes, G. Borthakur

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences